Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ORCHARD THERAPEUTICS (EUROPE) LIMITED

Company number 09759506

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
16 May 2017 SH03 Purchase of own shares.
28 Apr 2017 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
28 Apr 2017 SH06 Cancellation of shares. Statement of capital on 29 March 2017
  • GBP 314.50175
26 Apr 2017 SH01 Statement of capital following an allotment of shares on 29 March 2017
  • GBP 388.50175
09 Mar 2017 SH01 Statement of capital following an allotment of shares on 9 March 2017
  • GBP 315.50175
27 Feb 2017 SH01 Statement of capital following an allotment of shares on 27 February 2017
  • GBP 307.25175
23 Feb 2017 TM01 Termination of appointment of Helen Wise as a director on 23 December 2016
14 Feb 2017 CS01 Confirmation statement made on 14 February 2017 with updates
13 Feb 2017 SH01 Statement of capital following an allotment of shares on 2 February 2017
  • GBP 304.05
16 Jan 2017 AD01 Registered office address changed from , Octagon Point 5 Cheapside, London, EC2V 6AA to 245 Hammersmith Road 3rd Floor London W6 8PW on 16 January 2017
01 Nov 2016 CS01 Confirmation statement made on 1 November 2016 with updates
15 Sep 2016 CS01 Confirmation statement made on 1 September 2016 with updates
08 Jul 2016 AP01 Appointment of Dr Helen Wise as a director on 30 June 2016
08 Jul 2016 TM01 Termination of appointment of Chris Williams as a director on 30 June 2016
01 Jun 2016 AD01 Registered office address changed from , 90 High Holborn, London, WC1V 6XX, United Kingdom to 245 Hammersmith Road 3rd Floor London W6 8PW on 1 June 2016
19 May 2016 SH01 Statement of capital following an allotment of shares on 19 April 2016
  • GBP 153.36667
17 May 2016 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
11 May 2016 MR01 Registration of charge 097595060001, created on 27 April 2016
04 Mar 2016 SH01 Statement of capital following an allotment of shares on 6 February 2016
  • GBP 143.37
23 Feb 2016 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
23 Feb 2016 SH08 Change of share class name or designation
11 Feb 2016 AP01 Appointment of Dr Hubert Baburaj Gaspar as a director on 6 February 2016
10 Feb 2016 AP01 Appointment of Mr Benjamin Adam Auspitz as a director on 6 February 2016
09 Feb 2016 AP01 Appointment of Mr Chris Williams as a director on 6 February 2016
09 Feb 2016 AA01 Current accounting period extended from 30 September 2016 to 31 December 2016